Claret Asset Management Corp cut its stake in shares of Varex Imaging Co. (NASDAQ:VREX – Free Report) by 12.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 40,444 shares of the company’s stock after selling 5,560 shares during the period. Claret Asset Management Corp owned approximately 0.10% of Varex Imaging worth $590,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Wealthfront Advisers LLC bought a new stake in shares of Varex Imaging in the 4th quarter valued at about $18,900,000. Boston Partners bought a new stake in Varex Imaging in the fourth quarter valued at approximately $8,718,000. Russell Investments Group Ltd. increased its stake in Varex Imaging by 510.7% in the fourth quarter. Russell Investments Group Ltd. now owns 471,612 shares of the company’s stock valued at $6,881,000 after purchasing an additional 394,381 shares in the last quarter. Royce & Associates LP raised its holdings in Varex Imaging by 70.4% in the fourth quarter. Royce & Associates LP now owns 746,770 shares of the company’s stock worth $10,895,000 after purchasing an additional 308,629 shares during the period. Finally, LSV Asset Management boosted its position in shares of Varex Imaging by 826.3% during the fourth quarter. LSV Asset Management now owns 326,979 shares of the company’s stock worth $4,771,000 after purchasing an additional 291,679 shares in the last quarter.
Wall Street Analyst Weigh In
Several analysts recently commented on the company. StockNews.com raised Varex Imaging from a “hold” rating to a “buy” rating in a research note on Friday, February 7th. Oppenheimer decreased their price target on shares of Varex Imaging from $30.00 to $23.00 and set an “outperform” rating for the company in a research note on Friday, February 7th. Finally, B. Riley reissued a “buy” rating and set a $22.00 price target (up from $21.00) on shares of Varex Imaging in a research report on Friday, February 7th.
Insider Buying and Selling
In related news, SVP Kimberley E. Honeysett sold 4,007 shares of the business’s stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $12.81, for a total value of $51,329.67. Following the completion of the transaction, the senior vice president now owns 4,002 shares of the company’s stock, valued at $51,265.62. The trade was a 50.03 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Sunny Sanyal sold 8,749 shares of the stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $11.24, for a total transaction of $98,338.76. Following the sale, the chief executive officer now owns 190,193 shares in the company, valued at $2,137,769.32. This represents a 4.40 % decrease in their position. The disclosure for this sale can be found here. 4.30% of the stock is currently owned by insiders.
Varex Imaging Trading Up 2.2 %
Varex Imaging stock opened at $7.32 on Friday. Varex Imaging Co. has a 52 week low of $7.11 and a 52 week high of $17.46. The stock has a market capitalization of $301.58 million, a P/E ratio of -6.26 and a beta of 0.65. The stock has a 50-day simple moving average of $11.35 and a 200 day simple moving average of $13.08. The company has a debt-to-equity ratio of 1.02, a quick ratio of 2.50 and a current ratio of 4.36.
Varex Imaging (NASDAQ:VREX – Get Free Report) last announced its quarterly earnings results on Thursday, February 6th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.03. Varex Imaging had a positive return on equity of 4.00% and a negative net margin of 5.79%. Analysts expect that Varex Imaging Co. will post 0.53 earnings per share for the current year.
Varex Imaging Company Profile
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
Read More
- Five stocks we like better than Varex Imaging
- Where Do I Find 52-Week Highs and Lows?
- AppLovin: Can Record Profits Overcome Market Skepticism?
- EV Stocks and How to Profit from Them
- MarketBeat Week in Review – 04/14 – 04/18
- How to find penny stocks to invest and trade
- 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks
Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.